Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Parkinsonism Relat Disord. 2015 Dec 23;23:86–90. doi: 10.1016/j.parkreldis.2015.12.015

Table 1.

General characteristics of human subjects

PD Control
Number 101 68
Age (year; mean ± SD) 68.78 ± 9.36 65.92 ± 9.07
Gender (M/F) 55/46 32/36
Minor Allele Frequency 0.371 0.375
Genotype (WT/HET/HOM) 41/44/16 25/35/8
FOG-Q (mean ± SD) 4.86 ± 5.43
Disease Duration (years) 6.20 ± 5.88
UPDRS-III-ON (mean ± SD) 27.33 ± 19.52
UPDRS-III-OFF* (mean ± SD) 34.76 ± 21.07
LEDD** (mean ± SD) 659.06 ± 461.54
Minor Allele Frequency Subjects with Freezing of Gait 0.381
Genotype (WT/HET/HOM) Subjects with Freezing of Gait 32/35/13
FOG-Q (mean ± SD) Subjects with Freezing of Gait 6.14 ± 5.42
Disease Duration (years) Subjects with Freezing of Gait 7.23 ± 6.14
*

Only 71 subjects were able to complete the UPDRS-III while unmedicated.

**

The data were unavailable for 2 subjects.